14-01-2021
Aker BioMarine launches INVI, a novel protein for human consumption
Aker BioMarine is expanding its ingredient portfolio with the launch of INVI, a hydrolyzed protein isolate with a complete...
14-01-2021
Aker BioMarine launches INVI, a novel protein for human consumption
Aker BioMarine is expanding its ingredient portfolio with the launch of INVI, a hydrolyzed protein isolate with a complete...
14-01-2021
Aker BioMarine launches INVI, a novel protein for human consumption
Aker BioMarine is expanding its ingredient portfolio with the launch of INVI, a hydrolyzed protein isolate with a complete...
14-01-2021
Aker BioMarine launches INVI, a novel protein for human consumption
Aker BioMarine is expanding its ingredient portfolio with the launch of INVI, a hydrolyzed protein isolate with a complete...
14-01-2021
Aker BioMarine launches INVI, a novel protein for human consumption
Aker BioMarine is expanding its ingredient portfolio with the launch of INVI, a hydrolyzed protein isolate with a complete...
14-01-2021
Aker BioMarine launches INVI, a novel protein for human consumption
Aker BioMarine is expanding its ingredient portfolio with the launch of INVI, a hydrolyzed protein isolate with a complete...
14-01-2021
Aker BioMarine launches INVI, a novel protein for human consumption
Aker BioMarine is expanding its ingredient portfolio with the launch of INVI, a hydrolyzed protein isolate with a complete...
11-01-2021
Aker BioMarine signs first pharmaceutical agreement for development of therapies based on LYSOVETA™
Aker BioMarine has entered into an agreement with serial biotech entrepreneur Dr. Michael Davidson and his wholly owned...
06-01-2021
Aker BioMarine appoints Valentina Tapia to lead its QRILL strategy in Chile
Valentina Tapia joins Aker BioMarine in Chile, serving as the company’s Sales Director for QRILL – the line of products...